TY - JOUR
T1 - Melioidosis in travelers
T2 - An analysis of Dutch melioidosis registry data 1985–2018
AU - Birnie, Emma
AU - Savelkoel, Jelmer
AU - Reubsaet, F.
AU - Roelofs, Joris J.T.H.
AU - Soetekouw, R.
AU - Kolkman, Saskia
AU - Cremers, Anne Lia
AU - Grobusch, Martin P.
AU - Notermans, Daan W.
AU - Wiersinga, W. Joost
AU - Rozemeijer, Wouter
AU - Rijkeboer, Annemieke
AU - Scholing, Maarten
AU - van Dijk, K.
AU - Mascini, Ellen M.
AU - van der Veen, Henk
AU - van den Bijllaardt, Wouter
AU - de Vries, Maaike
AU - Smeets, Leonard C.
AU - Ott, Alewijn
AU - van Krimpen, Kees
AU - Herpers, Bjorn L.
AU - Watttel-Louis, G. Hanke
AU - Waar, Karola
AU - Schwandt, Noortje L.Q.
AU - Maat, Ianthe
AU - Dofferhoff, Anthonius S.M.
AU - Vermeulen, Joost N.
AU - van Westreenen, Mireille
AU - de Man, P.
AU - Hofland, Regina W.
AU - van Gorp, J.
AU - Thijsen, Steven
AU - van der Velden, Lieven B.
AU - Verduin, Cornelis M.
N1 - Funding Information:
This work was supported by a Research Grant (2018) from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the Academic Medical Center PhD scholarship award [grant number: 22162 ] to EB; WJW received financial support through a VIDI-grant of The Netherlands Organization for Scientific Research [NWO; VIDI grant number: 9171647 ].
Publisher Copyright:
© 2019 The Authors
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Background: Melioidosis, caused by the Gram-negative bacterium Burkholderia pseudomallei, is an opportunistic infection across the tropics. Here, we provide a systematic overview of imported human cases in a non-endemic country over a 25-year period. Methods: All 55 Dutch microbiology laboratories were contacted in order to identify all B. pseudomallei positive cultures from 1990 to 2018. A response rate of 100% was achieved. Additionally, a systematic literature search was performed, medical-charts reviewed, and tissue/autopsy specimens were re-assessed. Results: Thirty-three travelers with melioidosis were identified: 70% male with a median-age of 54 years. Risk factors were present in most patients (n = 23, 70%), most notably diabetes (n = 8, 24%) and cystic fibrosis (n = 3, 9%). Countries of acquisition included Thailand, Brazil, Indonesia, Panama, and The Gambia. Disease manifestations included pneumonia, intra-abdominal abscesses, otitis externa, genitourinary, skin-, CNS-, and thyroid gland infections. Twelve (36%) patients developed sepsis and/or septic shock. Repeat episodes of active infection were observed in five (15%) and mortality in four (12%) patients. Post-mortem analysis showed extensive metastatic (micro)abscesses amongst other sites in the adrenal gland and bone marrow. Conclusions: The number of imported melioidosis is likely to increase, given rising numbers of (immunocompromised) travelers, and increased vigilance of the condition. This first systematic retrospective surveillance study in a non-endemic melioidosis country shows that imported cases can serve as sentinels to provide information about disease activity in areas visited and inform pre-travel advice and post-travel clinical management.
AB - Background: Melioidosis, caused by the Gram-negative bacterium Burkholderia pseudomallei, is an opportunistic infection across the tropics. Here, we provide a systematic overview of imported human cases in a non-endemic country over a 25-year period. Methods: All 55 Dutch microbiology laboratories were contacted in order to identify all B. pseudomallei positive cultures from 1990 to 2018. A response rate of 100% was achieved. Additionally, a systematic literature search was performed, medical-charts reviewed, and tissue/autopsy specimens were re-assessed. Results: Thirty-three travelers with melioidosis were identified: 70% male with a median-age of 54 years. Risk factors were present in most patients (n = 23, 70%), most notably diabetes (n = 8, 24%) and cystic fibrosis (n = 3, 9%). Countries of acquisition included Thailand, Brazil, Indonesia, Panama, and The Gambia. Disease manifestations included pneumonia, intra-abdominal abscesses, otitis externa, genitourinary, skin-, CNS-, and thyroid gland infections. Twelve (36%) patients developed sepsis and/or septic shock. Repeat episodes of active infection were observed in five (15%) and mortality in four (12%) patients. Post-mortem analysis showed extensive metastatic (micro)abscesses amongst other sites in the adrenal gland and bone marrow. Conclusions: The number of imported melioidosis is likely to increase, given rising numbers of (immunocompromised) travelers, and increased vigilance of the condition. This first systematic retrospective surveillance study in a non-endemic melioidosis country shows that imported cases can serve as sentinels to provide information about disease activity in areas visited and inform pre-travel advice and post-travel clinical management.
KW - Burkholderia pseudomallei
KW - Fever in returned travelers
KW - Melioidosis
KW - Surveillance
KW - Travel medicine
UR - http://www.scopus.com/inward/record.url?scp=85070212099&partnerID=8YFLogxK
U2 - 10.1016/j.tmaid.2019.07.017
DO - 10.1016/j.tmaid.2019.07.017
M3 - Article
C2 - 31369898
AN - SCOPUS:85070212099
SN - 1477-8939
VL - 32
JO - Travel Medicine and Infectious Disease
JF - Travel Medicine and Infectious Disease
M1 - 101461
ER -